Intellia Therapeutics, Inc.

NTLA·NASDAQ·$12.61Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report09/08/26 8-KCurrent report09/04/26 8-KCurrent report08/06/26 8-KCurrent report06/15/26 8-KCurrent report06/10/26

Prospectuses and Registrations

424B5Prospectus supplement04/29/26 424B5Prospectus supplement04/27/26 424B5Prospectus supplement03/02/26 S-8Registration of securities for employees02/26/26 S-8Registration of securities for employees06/11/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEF 14ADefinitive proxy04/30/25 DEFA14AAdditional proxy materials04/30/25 DEF 14ADefinitive proxy04/29/24

Ownership

Form 3Initial insider ownership10/28/26 Form 4Insider transaction10/28/26 Form 4Insider transaction10/06/26 144Proposed sale of securities10/05/26 Form 4Insider transaction08/24/26

Other

ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders04/30/25 ARSAnnual report to shareholders04/29/24 ARSAnnual report to shareholders04/18/23 CT ORDERCT ORDER09/01/20